T2 Biosystems to Present at the Janney Healthcare Conference 2019
August 29 2019 - 7:30AM
T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the
development and commercialization of innovative medical diagnostic
products for critical unmet needs in healthcare, announced today
that John McDonough, chairman and chief executive officer, and John
Sprague, chief financial officer, are scheduled to present at the
Janney Healthcare Conference 2019. The conference is being held on
September 9-10 at the Union League Club in New York City.
Mr. McDonough and Mr. Sprague are scheduled to present on
Monday, September 9, 2019 at 12:35-1:15 p.m. ET. Mr. McDonough and
Mr. Sprague will be available for one-on-one meetings during the
conference. The presentation will be webcast live and available for
replay, and may be accessed by visiting the Investors/Events &
Presentations section of the Company’s website at
www.t2biosystems.com. A replay of the webcast will be available
shortly after the conclusion of the presentation and will be
archived on the Company's website for two weeks following the
presentation.
About T2 BiosystemsT2 Biosystems, a leader in
the development and commercialization of innovative medical
diagnostic products for critical unmet needs in healthcare, is
dedicated to improving patient care and reducing the cost of care
by helping clinicians effectively treat patients faster than ever
before. T2 Biosystems’ products include the T2Dx® Instrument,
T2Candida® Panel, and T2Bacteria® Panel, which was recently
announced as the first and only in-vitro diagnostic test to receive
approval for a New Technology Add-on Payment (NTAP) by CMS, are
powered by the proprietary T2 Magnetic Resonance (T2MR®)
technology. T2 Biosystems has an active pipeline of future
products, including products for the detection of additional
species and antibiotic resistance markers of sepsis pathogens, and
tests for Lyme disease.
Media Contact:Gina Kent, Vault
Communicationsgkent@vaultcommunications.com610-455-2763
Investor Contact:Zack Kubow, W2O Groupzkubow@w2ogroup.com
415-658-6436
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Mar 2024 to Apr 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Apr 2023 to Apr 2024